A case study from Diagnexia The global shortage of pathologists has posed significant challenges for healthcare providers, increasing workloads, leading to backlogs, and delaying critical diagnoses. To address these challenges, East...

Diagnexia and Stratipath: Collaboration expands AI-based risk profiling tools Diagnexia has announced a partnership with Stratipath AB to bring Stratipath Breast, an AI-based prognostic risk profiling tool, to healthcare providers...

Naperville, IL, USA, 28th January 2025 – Diagnexia announces the launch of its enterprise-grade digital pathology platform that seamlessly connects US laboratories to its broad network of board-certified sub-specialty pathologists. Built for...

United Kingdom – Diagnexia UK Limited is delighted to announce its recent accreditation to ISO 15189:2022 for their digital pathology service, a globally recognised standard for medical laboratory requirements for quality and competence....

Oxford, UK – 15/10/2024 – Diagnexia, the clinical digital pathology service of Deciphex, proudly announces the opening of a new, cutting-edge histopathology laboratory in Oxford. This advanced facility is set to significantly expand...

Toronto, Canada, May 19, 2023 — Diagnexia Canada Limited, owned by Deciphex Limited and internationally recognized as a leading provider of pathology services, is delighted to announce the launch of its cutting-edge accessioning facility in...